The Future of Precision Diagnostics | Aldatu Biosciences CEO Iain MacLeod

In this episode of The Healthcare Theory, we’re joined by Iain MacLeod, co-founder of Aldatu Biosciences, to explore their groundbreaking work in diagnostics for HIV and emerging diseases. Aldatu addresses the global challenge of affordable and accessible drug-resistance testing, focusing on resource-limited settings. Iain shares insights on the innovative Panda technology, which enables rapid and accurate detection of resistant strains even in the most variable viruses. We discuss the journey of developing diagnostics like COVID-19 tests, the role of public benefit corporations in social impact, and navigating global healthcare markets. Don’t miss this in-depth discussion on transforming healthcare through innovation in diagnostics.